CKD Bio Inventory

The latest inventory for 063160.KS is $91B as of June 2026. That compares with $89B in the prior-year period — up 2.6% year over year. Investors often review this figure alongside CKD Bio's historical trend and sector peers before judging valuation or financial health.

Over the past year, 063160.KS's inventory moved from $89B to $91B — a 2.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in CKD Bio's operating scale or balance-sheet position.

A inventory figure of $91B for 063160.KS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 063160.KS's inventory ($91B), review year-over-year change from $89B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.